449 related articles for article (PubMed ID: 16103061)
1. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
3. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
4. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
[TBL] [Abstract][Full Text] [Related]
7. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
[TBL] [Abstract][Full Text] [Related]
8. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
Simon M; von Deimling A; Larson JJ; Wellenreuther R; Kaskel P; Waha A; Warnick RE; Tew JM; Menon AG
Cancer Res; 1995 Oct; 55(20):4696-701. PubMed ID: 7553651
[TBL] [Abstract][Full Text] [Related]
9. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
10. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
[TBL] [Abstract][Full Text] [Related]
12. Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1.
Niedermayer I; Feiden W; Henn W; Steilen-Gimbel H; Steudel WI; Zang KD
J Neuropathol Exp Neurol; 1997 Aug; 56(8):879-86. PubMed ID: 9258258
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
14. Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.
Martínez-Glez V; Alvarez L; Franco-Hernández C; Torres-Martin M; de Campos JM; Isla A; Vaquero J; Lassaletta L; Castresana JS; Casartelli C; Rey JA
Cancer Genet Cytogenet; 2010 Jan; 196(1):1-6. PubMed ID: 19963129
[TBL] [Abstract][Full Text] [Related]
15. GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.
Piaskowski S; Rieske P; Szybka M; Wozniak K; Bednarek A; Płuciennik E; Jaskolski D; Sikorska B; Liberski PP
Cancer Genet Cytogenet; 2005 Oct; 162(1):63-7. PubMed ID: 16157202
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of S6K overexpression in meningioma progression.
Surace EI; Lusis E; Haipek CA; Gutmann DH
Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
